Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan.
Takashi KadowakiMasakazu HanedaHiroshi ItoKazuyo SasakiMiyuki MatsukawaYuka YamadaPublished in: Advances in therapy (2019)
Japan Pharmaceutical Information Center clinical trials database identifier: Japic CTI-153047. Plain language summary available for this article.